Evidence map›Paper›PMID 36767268›Full record

ArticleInternational journal of environmental research and public health2023

Arsenic: A Perspective on Its Effect on Pioglitazone Bioavailability.

María Cruz Del Rocío Terrones-Gurrola, Patricia Ponce-Peña, José Manuel Salas-Pacheco, Abelardo Camacho-Luis, Amaury de Jesús Pozos-Guillén, Guillermo Nieto-Delgado, Olga Dania López-Guzmán, Angel Antonio Vértiz-Hernández

Open access · goldAbstract read
In one paragraph

Article in International journal of environmental research and public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

María Cruz Del Rocío Terrones-GurrolaCoordinación Académica Región Altiplano, Universidad Autónoma de San Luis Potosí, Matehuala 78700, Mexico.ORCID 0000-0002-2165-4674
Patricia Ponce-PeñaFacultad de Ciencias Químicas, Universidad Juárez del Estado de Durango, Durango 34120, Mexico.ORCID 0000-0002-8510-5703
José Manuel Salas-PachecoInstituto de Investigaciones Científicas, Universidad Juárez del Estado de Durang, Durango 34000, Mexico.
Abelardo Camacho-LuisCentro de Investigación en Alimentos y Nutrición, Facultad de Medicina y Nutrición, Universidad Juárez del Estado de Durang, Durango 34000, Mexico.ORCID 0000-0002-0054-2569
Amaury de Jesús Pozos-GuillénFacultad de Estomatología, Universidad Autónoma de San Luis Potosí, San Luis Potosí 78290, Mexico.
Guillermo Nieto-DelgadoDepartamento de Físico-Matemáticas, Universidad Autónoma de San Luis Potosí, San Luis Potosí 78290, Mexico.
Olga Dania López-GuzmánFacultad de Ciencias Químicas, Universidad Juárez del Estado de Durango, Durango 34120, Mexico.
Angel Antonio Vértiz-HernándezCoordinación Académica Región Altiplano, Universidad Autónoma de San Luis Potosí, Matehuala 78700, Mexico.
Autonomous University of San Luis Potosí · MXUniversidad Juárez del Estado de Durango · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Arsenic (As) is a common contaminant in drinking water in northeastern Mexico, which reduces the expression of cytochrome P450 (CYP 450). This enzyme group metabolizes numerous drugs, such as oral antidiabetic drugs such as pioglitazone (61% CYP 3A4, 49% CYP 2C8). When CYP 450's function is inadequate, it has decreased therapeutic activity in type 2 diabetes mellitus (T2DM). This study aimed to establish the effect of As on pioglitazone metabolism in patients with T2DM. METHODOLOGY: Urine, water, and plasma samples from a healthy population (

resultsThe healthy and T2DM groups were exposed via drinking water to >0.010 ppm, Ka values with a factor of 4.7 higher, Cl 1.42 lower, and ABCt 1.26 times higher concerning the healthy group. In silico analysis (DFT) of CYP 3A4 and CYP 2C8 isoforms showed the substitution of the iron atom by As in the active sites of the enzymes.

conclusionsThe results indicate that the substitution of Fe for As modifies the enzymatic function of CYP 3A4 and CYP 2C8 isoforms, altering the metabolic process of CYP 2D6 and CYP 3A4 in patients with T2DM. Consequently, the variation in metabolism alters the bioavailability of pioglitazone and the expected final effect.

Indexed as

ArsenicDiabetes Mellitus, Type 2Drinking WaterBiological AvailabilityCytochrome P-450 Enzyme SystemHumansMicrosomes, LiverPioglitazoneArsenicCytochrome P-450 Enzyme SystemDrinking WaterPioglitazonearsenicCYP 450ironmetabolismpioglitazone

Identifiers

PMID36767268
PMCPMC9915544
OpenAlexW4317528984

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.